NECTAR LIFESCIENCES
Quarterly Results Analysis [Dec2023]
NECTAR LIFESCIENCES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹452 Cr | ₹398 Cr | ₹394 Cr | ₹389 Cr | ₹344 Cr | ₹389 Cr | ₹403 Cr | ₹476 Cr |
Expenses | ₹410 Cr | ₹371 Cr | ₹359 Cr | ₹371 Cr | ₹343 Cr | ₹396 Cr | ₹361 Cr | ₹427 Cr |
Operating Income | ₹42 Cr | ₹27 Cr | ₹36 Cr | ₹18 Cr | ₹1 Cr | ₹-7 Cr | ₹42 Cr | ₹49 Cr |
Other Income | ₹0 Cr | ₹11 Cr | ₹0 Cr | ₹18 Cr | ₹13 Cr | ₹11 Cr | ₹0 Cr | ₹1 Cr |
Interest | ₹25 Cr | ₹21 Cr | ₹18 Cr | ₹20 Cr | ₹17 Cr | ₹21 Cr | ₹21 Cr | ₹17 Cr |
Depreciation | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr |
Profit Before Tax | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹-18 Cr | ₹-32 Cr | ₹6 Cr | ₹18 Cr |
Profit After Tax | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹-9 Cr | ₹-22 Cr | ₹4 Cr | ₹12 Cr |
EPS | ₹0.07 | ₹0.05 | ₹0.08 | ₹0.16 | ₹-0.41 | ₹-1.00 | ₹0.17 | ₹0.52 |
Industry Peers & Returns | 1W | 1M | 1Y |
NECTAR LIFESCIENCES | -3.1% | -24% | 93.6% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
NECTAR LIFESCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 13.62 % |
Y-o-Y | 31.40 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹452 Cr | 13.62 | |
Sep2023 | ₹398 Cr | 0.97 | |
Jun2023 | ₹394 Cr | 1.37 | |
Mar2023 | ₹389 Cr | 12.99 | |
Dec2022 | ₹344 Cr | -11.46 | |
Sep2022 | ₹389 Cr | -3.57 | |
Jun2022 | ₹403 Cr | -15.37 | |
Mar2022 | ₹476 Cr | - |
NECTAR LIFESCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 57.04 % |
Y-o-Y | 2,817.70 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹42 Cr | 57.04 | |
Sep2023 | ₹27 Cr | -24.41 | |
Jun2023 | ₹36 Cr | 96.47 | |
Mar2023 | ₹18 Cr | 1,150.97 | |
Dec2022 | ₹1 Cr | Positive | |
Sep2022 | ₹-7 Cr | Negative | |
Jun2022 | ₹42 Cr | -14.94 | |
Mar2022 | ₹49 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 38.22 % |
Y-o-Y | 2,121.43 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 9.33% | 38.22 | |
Sep2023 | 6.75% | -25.17 | |
Jun2023 | 9.02% | 93.98 | |
Mar2023 | 4.65% | 1,007.14 | |
Dec2022 | 0.42% | Positive | |
Sep2022 | -1.9% | Negative | |
Jun2022 | 10.37% | 0.48 | |
Mar2022 | 10.32% | - |
NECTAR LIFESCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 53.88 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹2 Cr | 53.88 | |
Sep2023 | ₹1 Cr | -44.15 | |
Jun2023 | ₹2 Cr | -50.46 | |
Mar2023 | ₹4 Cr | Positive | |
Dec2022 | ₹-9 Cr | Negative | |
Sep2022 | ₹-22 Cr | Negative | |
Jun2022 | ₹4 Cr | -66.57 | |
Mar2022 | ₹12 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 34.62 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 0.35 % | 34.62 | |
Sep2023 | 0.26 % | -43.48 | |
Jun2023 | 0.46 % | -51.58 | |
Mar2023 | 0.95 % | Positive | |
Dec2022 | -2.7 % | Negative | |
Sep2022 | -5.78 % | Negative | |
Jun2022 | 0.97 % | -60.41 | |
Mar2022 | 2.45 % | - |
NECTAR LIFESCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 40.00 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.07 | 40.00 | |
Sep2023 | ₹0.05 | -37.50 | |
Jun2023 | ₹0.08 | -50.00 | |
Mar2023 | ₹0.16 | Positive | |
Dec2022 | ₹-0.41 | Negative | |
Sep2022 | ₹-1 | Negative | |
Jun2022 | ₹0.17 | -67.31 | |
Mar2022 | ₹0.52 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD